Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Molecular Cancer Therapeutics|April 26, 2024
TNIK inhibition sensitizes TNIK-overexpressing lung squamous cell carcinoma to radiotherapyTriet Nguyen, Francesca Anna Carrieri, Nick Connis, et al.
JAMA Network Open|June 2, 2023
Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled TrialNancy Y Lee, Jonathan Harris, John Kim, et al.
Retina (Philadelphia, Pa.)|December 16, 2021
CHARACTERIZING COVID-19-RELATED RETINAL VASCULAR OCCLUSIONS: A Case Series and Review of the LiteratureAlex Fonollosa, José Hernández-Rodríguez, Carlos Cuadros, et al.
Molecular Cancer Therapeutics|June 2, 2026
Suppression of AKT Activation Through LZK Inhibition Limits Tumor Growth in Esophageal and Head and Neck CancersMeghri Katerji, Maxine R Rubin, Eric Lindberg, et al.
Medical Mycology|October 17, 2025
Deep learning for the identification of Candida spp. directly from blood culture gram stains from candidemia patientsJuan Carlos Cuevas-Tello, Azael Monreal-de la Rosa, Juan Luis Quistian-Navarro, et al.
Cancers|July 2, 2021
NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck CancerJulie E Bauman, Jonathan Harris, Ravindra Uppaluri, et al.
Plos Biology|March 13, 2020
Endosomal Wnt signaling proteins control microtubule nucleation in dendritesAlexis T Weiner, Dylan Y Seebold, Pedro Torres-Gutierrez, et al.
Viruses|May 28, 2025
Genotypic Characterization of Human Respiratory Syncytial Viruses Detected in Mexico Between 2021 and 2024Nadia Martínez-Marrero, Juan Carlos Muñoz-Escalante, Rosa Maria Wong-Chew, et al.
Frontiers in Global Women'S Health|November 12, 2025
Effect of self-stigma on personal recovery: sex differences in people with psychotic spectrum disordersDaniela Leon-Morales, Jose-Blas Navarro, Maria Lamarca, et al.
Microorganisms|August 26, 2023
Safety and Tolerability of Six Months of Isoniazid Plus Pyridoxine or Three Months of Rifampicin for Tuberculosis among Subjects with Diabetes Mellitus: A Randomized TrialKarla M Tamez-Torres, Norma Mongua-Rodríguez, Leticia Ferreyra-Reyes, et al.
Pageof 15